Associated Papers
Role of mGluR7 in Alzheimer's disease: pathophysiological insights and therapeutic approaches.
Hunjan G et al.
Inflammopharmacology, 2025
GRM7 deficiency, from excitotoxicity and neuroinflammation to neurodegeneration: Systematic review of GRM7 deficient patients.
Zaki-Dizaji M et al.
Brain, Behavior, & Immunity - Health, 2024
Therapeutic Potential for Metabotropic Glutamate Receptor 7 Modulators in Cognitive Disorders.
Parent HH et al.
Molecular Pharmacology, 2024
GRM7-related disorder: five additional patients from three independent families and review of the literature.
Januel L et al.
European Journal of Medical Genetics, 2024
GRM7 gene mutations and consequences for neurodevelopment.
Freitas GA et al.
Pharmacology, Biochemistry, and Behavior, 2023
Single-cell sequencing reveals CD133+CD44--originating evolution and novel stemness related variants in human colorectal cancer.
Zhang X et al.
Ebiomedicine, 2022
35785618 (PubMed )
Supplement: mmc1.xlsx › Supplementary_Table_6b
A large consanguineous family with a homozygous Metabotropic Glutamate Receptor 7 (mGlu7) variant and developmental epileptic encephalopathy: Effect on protein structure and ligand affinity.
Jdila MB et al.
Orphanet Journal of Rare Diseases, 2021
Pathogenic GRM7 Mutations Associated with Neurodevelopmental Disorders Impair Axon Outgrowth and Presynaptic Terminal Development.
Song JM et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2021
Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.
Marafi D et al.
Annals of Clinical and Translational Neurology, 2020
Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders.
Fisher NM et al.
Frontiers in Molecular Neuroscience, 2018
Exome sequencing in mostly consanguineous Arab families with neurologic disease provides a high potential molecular diagnosis rate.
Charng WL et al.
Bmc Medical Genomics, 2016
Select a paper to view details